| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | treprostinil | FAERS: 6 | US FAERS | |
| 2 | Amoxicillin | FAERS: 4 | US FAERS | |
| 3 | Docetaxel | FAERS: 2 | US FAERS | |
| 4 | Moxifloxacin | FAERS: 2 | US FAERS | |
| 5 | quinupristin-dalfopristin | FAERS: 2 | US FAERS | |
| 6 | Azithromycin | FAERS: 1 | US FAERS | |
| 7 | Dexmedetomidine | FAERS: 1 | US FAERS | |
| 8 | Ganciclovir | FAERS: 1 | US FAERS | |
| 9 | Hemin | FAERS: 1 | US FAERS | |
| 10 | Morphine | FAERS: 1 | US FAERS | |
| 11 | Potassium Chloride | FAERS: 1 | US FAERS | |
| 12 | Propofol | FAERS: 1 | US FAERS | |
| 13 | Vancomycin | FAERS: 1 | US FAERS | |
| 14 | Vinorelbine | FAERS: 1 | US FAERS | |
| 15 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 16 | romidepsin | FAERS: 1 | US FAERS | |
| 17 | Bisacodyl | OFFSIDES | ||
| 18 | dolasetron | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.